Tandem T:Slim X2 User Manual page 39

You have the ability to view a
•
variety of data right on your screen,
including the time and amount
of your last bolus, your total
insulin delivery by day, as well as
broken into basal, food bolus, and
correction bolus.
When paired with Dexcom G5
•
Mobile Transmitter and Sensor,
your t:slim X2 System can receive
CGM readings every 5 minutes,
which are displayed as a trend
graph on the Home Screen. You
can also program your pump to
alert you when your CGM readings
are above or below a given level, or
are rising or falling quickly. Unlike
the readings from a standard blood
glucose meter, CGM readings allow
you to view trends in real time, as
well as capture information when
you would otherwise be unable
to check your blood sugar, such
as while you are asleep. This
information can be useful for you
and your health care provider
when considering changes to
your therapy. In addition, the
programmable alerts can help you
to spot potential low or high blood
Customer Technical Support: (877) 801-6901
Chapter 2 – Important Safety Information
glucose sooner than you would
using a only a blood glucose meter.
CGM use has been shown to
•
increase time in your target glucose
range, without increasing time
spent above or below your target
range. Real-time CGM can help
improve diabetes control (lower A1c
values, reducing glycemic variability
and time spent in low and high
blood glucose ranges) which
1, 2, 3
can help reduce diabetes related
complications. These benefits can
4, 5
be seen especially with using real-
time CGM at least 6 days per week
and can be sustained over time.
some cases, patients perceived an
increase in their quality of life and
peace of mind when using real-time
CGM as well as reporting a high
satisfaction with CGM.
7
Garg S, Zisser H, Schwartz S, Bailey
1
T, Kaplan R, Ellis S, Jovanovic L.
Improvement in glycemic excursions
with a transcutaneous, real-time con-
tinuous glucose sensor: a randomized
controlled trial. Diabetes Care. 2006;
29:44-50.
JDRF CGM Study Group. Continu-
2
ous Glucose Monitoring and Intensive
Treatment of Type 1 Diabetes. NEJM
2008;359:1464-76.
Battelino. Effect of continuous glucose
3
monitoring of hypoglycemia in type 1
diabetes. Diabetes Care 2011; 34(4):
795-800.
The Diabetes Control and Complica-
4
tions Research Group. The effect of
intensive treatment of diabetes on the
development and progression of long-
term complications of insulin-depen-
dent diabetes mellitus. N Eng J Med.
2
In 1993; 329:997-1036.
6
Ohkubo Y, Kishikawa H, Araki E, et
5
al. Intensive insulin therapy prevents
progression of diabetic microvascular
complications in Japanese patients
with non-insulin dependent diabetes
mellitus: a randomized prospective
6-year study. Diabetes Res Clin Pract.
1995; 28:103-117.
39